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Abstract: Intensive care is one of the most challenging areas of modern medicine. Maintenance of 
glucose levels in intensive care unit (ICU) patients via control of insulin inputs is currently an active 
research field. The current paper presents the analysis of postmodern and nonlinear control methods for 
tight glycaemic control (TGC) under intensive care. Using a clinically validated ICU metabolic system 
model’s redefined version, an H∞-type robust controller is proposed and compared with a non-
conservative complex µ-synthesis method, where robust stability and nominal performance is met under 
multiplicative uncertainty. The model is rewritten in affine parameter varying form by choosing 
scheduling parameters and a quasi Affine Linear Parameter Varying (qALPV) controller is designed 
assuring performance and stability requirements. Closed loop simulation results are tested under 
MATLAB. 
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1. INTRODUCTION 
Critically ill patients admitted to the Intensive Care Unit 
(ICU) often display hyperglycaemia and insulin resistance 
associated with adverse outcomes (Krinsley (2004)), which 
are associated with increased morbidity and mortality (Capes 
et al. (2000)). Tight glycaemic control (TGC) can reduce 
these adverse outcomes (Chase et al. (2008)), as well as 
reducing economic costs (Van den Berghe (2006)). The goal 
of such a control can be realized by automated or semi-
automated treatments and, in this way, good outcome can be 
achieved with minimal extra clinical effort (Chase et al. 
(2006)). 
Several studies have shown that TGC can reduce mortality 
(Chase et al. (2008)), but several others have reported 
difficulty repeating these results (Griesdale (2009)). This 
difficulty is caused in large part due to the significant 
metabolic variability of ICU patients (Lin et al. (2008)). It 
presents an ideal application for model-based automation of 
insulin infusions for TGC. 
Accurate metabolic system models are a critical element. The 
best known model is the minimal model of Bergman et al. 
(1981), used primarily for clinical research studies. However, 
the model’s simplicity is a disadvantage, with significant 
components of glucose-insulin interaction neglected in its 
formulation, as they are not required or are managed in 
clinical experiments. 
Consequently, different models were derived from the 
minimal model, trying to generalize it to the ICU case. Wong 
et al. (2006) and Lotz et al. (2006) presented a third order 
model that better captured insulin losses and saturation 
dynamics. Van Herpe et al. (2007) created a fourth order 
model that accounted for further typical features of the ICU 
patient, although basic structure was retained. Pielmeier et al. 
(2009) created the ‘Glucosafe’ model that integrates a range 
of physiological models and parameters and accounts for the 
reduced rate of glucose gut absorption and saturation of 
insulin action in patients with reduced insulin sensitivity. 
Of these models, only Wong et al. (2006) and Lotz et al. 
(2006) (named in the followings as Canterbury-model) have 
been clinically applied and validated in TGC for ICU 
patients, as well as in other clinical experiments. An updated 
version of this model has recently appeared (Suhaimi et al. 
(2010)). 
Regarding the applied control strategies, it was proven that 
modeling and control are two tightly connected problems. 
However, most of the applied control methods in ICU 
focused on the minimal model (Makroglou et al. (2006)). 
Using the model of Suhaimi et al. (2010) the aim of the 
current paper is to develop modern robust control strategies 
for TGC. The authors focused on the optimization of the 
amount of insulin under exogenous disturbance and 
mismatch. Parameter variance is taken into account using H∞ 
and µ-synthesis robust linear control methods, but nonlinear 
model-based linear parameter varying (LPV) technique is 
also applied. 
The paper is structured as follows: first a brief description of 
the model is given, and then the applied control strategies are 
described. Robust controller design is followed presenting 
simulation results on the original nonlinear system. The 
comparison differences between the linear and nonlinear 
model based robust control methods are also revealed. 
 
 
 
   
 
2. THE CANTERBURY-MODEL 
Wong et al. (2006) developed a series of models based on a 
fundamental system with three compartments (Wong et al. 
(2006), Lin et al. (2008)) with recent redefinition in Suhaimi 
et al. (2010): 
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where the parameters are defined in Table 1, including 
typical values assigned to population constants. 
This model (as well as its earlier versions) was mainly based 
on the minimal model of Bergman et al. (1981). The 
Canterbury-model was first extended with one state variable 
to represent insulin bounded to interstitial sites, like the one 
presented in Wong et al. (2006): 
( ) ( ) ( )( ) ( ) ( )
( )
GG
EIG V
tP
tQ
tQGtGtStGp)t(G +
+
+−−=
α1
  (2/a) 
( ) ( ) ( )tkQtkItQ −=  (2/b) 
( ) ( )( )
( )
V
tu
tI
tnItI en
I
+
+
−=
α1
  . (2/c) 
The model captures insulin losses to the liver and kidneys 
(Lotz et al. (2006)) and saturation dynamics through the use 
of Michaelis-Menten functions. All models have their unique 
insulin sensitivity metric, with the aim to correlate the value 
derived from the gold-standard euglycaemic clamp method 
(Lotz et al. (2006)). Contrary to the earlier models, where 
both insulin sensitivity SI(t) and glucose clearance pG(t) were 
time-varying parameters, in Suhaimi et al. (2010) only SI(t) is 
time-varying (Hann et al. 2005). 
The insulin sensitivity metric is identified in real-time from 
data, and various methods have been examined in order to 
find the most accurate, but also computation time and cost 
efficient way including integral-based (Hann et al. (2005)) 
and stochastic (Lin et al. (2008)) parameter identification. 
In Suhaimi et al. (2010) the basal value of plasma glucose 
concentration GE was eliminated and replaced with two 
parameters representing endogenous glucose production 
EGPb and the glucose demand of the central nervous system 
CNS. Both of these values are considered constant. However, 
two additional states were added to capture the delay 
resulting from glucose absorption during enteral feeding with 
a second-order system. Saturation was added to keep the 
states within physiologically acceptable ranges. In real-life 
applications these limits are not often reached, therefore the 
gastric absorption system (1/d)-(1/f) can be considered linear 
and time-invariant. 
Furthermore, endogenous insulin production is included. 
However, no separate state variable was introduced. In earlier 
model versions, endogenous insulin production depended on 
exogenous insulin (Hann et al. (2005) and plasma insulin. 
Recent (yet unpublished) results show that the suppression of 
endogenous insulin secretion seen in normal and healthy 
diabetic individuals is not effective in critical illness. Hence 
uend can be considered constant (uend = uenb), negating (1/g). 
Table 1. Variables used in the Canterbury-model. 
Notation Unit Description Value 
State variables 
G mmol/L Plasma glucose concentration - 
Q mU/L 
Concentration of 
insulin bounded to 
interstitial sites 
- 
I mU/L Plasma insulin concentration - 
Model inputs 
D mmol/min Enteral glucose nutrition  
P mmol/min 
Glucose transfer from 
the gut to the 
bloodstream 
- 
uex mU/min External insulin - 
uend mU/min 
Endogenous insulin 
production - 
Parameters 
pG 1/min 
Endogenous glucose 
clearance 0.006 
SI L/mU/min Insulin sensitivity 2.25e-4 
αG L/mU Insulin effect 1/65 
EGPb mmol/min Endogenous glucose production 1.16 
CNS mmol/min Central nervous system glucose uptake 0.3 
VG L 
Insulin distribution 
volume 13.3 
k 1/min Effective life of insulin in the compartment 0.0198 
n 1/min First order decay rate from plasma 0.16 
αI L/mU 
Plasma insulin 
disappearance 0.0017 
VI L 
Insulin distribution 
volume 3.15 
k1 mU/min 
Endogenous insulin 
production base rate 4.79 
k2 - Generic constant 1.5 
k3 - Generic constant 1000 
uenb mU/min 
Basal endogenous 
insulin production 4.7221 
d1 1/min 
Transport rate between 
stomach and gut 0.0347 
d2 1/min 
Transport rate between 
gut and plasma 0.0069 
Pmax mmol/min Glucose flux saturation 6.11 
 
 
   
 
3. ROBUST CONTROL DESIGN USING COMPLEX μ 
SYNTHESIS 
Linear H∞, respectively μ control syntheses are promising 
methods on the palette of the robust control systems. These 
postmodern techniques date back to around two decades 
(Doyle et al. (1989). Progressively it gains ground by the 
more and more powerful computational soft- and hardware, 
(Balas et al. (1991), Zhou (1996)). One of the biggest 
advantages of these methodologies (beyond the well defined 
mathematical backgrounds) might be the robustness itself. 
Robustness against model mismatches, against disturbances.  
For robust control synthesis, let us consider the augmented 
system drawn in the Fig. 1. It includes the feedback structure 
of the model Gn and controller K, and elements associated 
with the uncertainty models and performance objectives. In 
the diagram, r is the reference, u is the control input (insulin 
inlet), y is the output (glucose and insulin levels), d is the 
disturbance (glucose), n is the measurement noise, and ze is 
the deviation of the output from the required one. The 
structure of the controller K may be partitioned into two 
parts: K = [Kr Ky], where Ky is the feedback part of the 
controller and Kr is the pre-filter part. 
One widespread approach of describing uncertainties is the 
unstructured formulation. Even if the precise uncertainty 
dynamics are unknown, usually an upper bound could be 
defined in frequency domain in order to characterize the 
mismatch. Complex uncertainties, neglected dynamics, 
respectively their (frequency depending) bounds could be 
classified into several groups.  
In our case, the input multiplicative uncertainty is preferred, 
because it specifies the digression, the frequency depending 
difference (in percentage) between the nominal and the actual 
plant. The uncertainties between the nominal model and the 
real plant is represented with Wm and Δm. Wm is assumed to be 
known, and it presents all a priori information about the 
neglected dynamics. The transfer function Δm is assumed to 
be stable and unknown with the norm condition, ║ Δm║∞ < 1. 
The formal definition of the multiplicative uncertainty is 
given by: 
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Necessary and sufficient conditions for robust stability and 
robust performance can be formulated in terms of the 
structured singular value denoted as μ, (Zhou (1996)). By 
introducing the so called linear fractional transformation 
(LFT) of the (P, K) pair one gets back the so-called the Δ – M 
structure (Zhou (1996)). In order to analyze the performance 
and robustness requirements, the closed loop system is 
expressed by the lower LFT of partition blocks M: 
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The robust stability (RS) can be guaranteed when the closed-
loop system is internally stable. The internal stability means 
that from all inputs to all outputs the created transfer function 
is stable. As a result 111 <∞M . 
This condition might be conservative, while the set of 
perturbation Δ is member of a bounded subset (Zhou (1996)). 
A less conservative solution of the problem is to structure 
uncertainties. This is the structured singular value μ and in 
this way 1/ μΔ(M) is the “size” of the smallest perturbation Δ, 
measured by its maximum singular value. As a result the 
robust stability can be reformulated as: 
11 1111 <⇔< ∞)M(    )M(sup µµ
ω
 . (5) 
The main goal of our synthesis is to guarantee robust 
performance (RP). The closed-loop system achieves robust 
performance if the performance objective is met: 
11 <⇔< ∞)M(    )M(sup µµ
ω
 . (6) 
Using μ it is possible to test both robust stability and robust 
performance in a non-conservative manner. Computation of μ 
can be done by D-K iteration (Gu et al (2005)). 
By adding other weighting functions, the degree of the H∞ 
controller will increase. To achieve RP the tuning of the 
additional considered weighting functions should be 
necessary. In other words, RP is guaranteed only for planned 
/ scheduled uncertainty. Therefore, it could be more practical 
to make investigations in the direction of non-linear control. 
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Fig. 1. Augmented closed loop interconnection. 
 
 
   
 
4. LPV MODELLING AND QALPV DESCRIPTION 
The H∞ and µ-synthesis method presented above was 
questioned over the linearized mathematical model of the 
glucose-insulin system. However, model-based controller 
design needs non-linear control strategies, to have a more 
closely behaviour to the real situation. This question is 
connected to the initial value problem and the answer is given 
by simulation results and by their evaluation in the 
followings. 
Linear Parameter Varying (LPV) system is a class of 
nonlinear systems, where the parameter could be an arbitrary 
time varying, piecewise-continuous and vector valued 
function denoted by ρ(t), defined on a compact set P (Lee 
(1997)): 
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Consequently, LPV systems provide a model paradigm that 
goes beyond the classical representation of nonlinear and 
linear systems (Lee (1997)). Basically, LPV systems can be 
seen as an extension of linear time-invariant (LTI) systems, 
where the relations are considered to be linear, but model 
parameters are assumed to be functions of a time-varying 
signal. 
To evaluate the system, the parameter trajectory is required to 
be known, either by measurement or by computation. Hence, 
by choosing parameter variables the system’s nonlinearity 
can be hidden, while the measured parameters describe the 
whole working domain of the designed controller. This 
methodology is used on different control solutions (Balas 
(2002)), which gave also a solution of the problem. 
4.1 qALPV modelling 
There are different descriptions of LPV systems (Lee 2005). 
In the quasi-affine description, a part of the state vector x(t) is 
equal with the ρ(t) scheduling parameters. The affine 
dependency of (7) with N))t(dim( =ρ  means: 
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Hence, the affine LPV system can be written as: 
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In (9) the parameters are varying between known minimal 
(
iρ ) and maximal ( iρ ) bounds (respectively the limits of 
theirs rates are known). 
 
4.2 qALPV modelling of the Canterbury Model 
Kovács et al. (2010) investigated qALPV modelling 
possibility of the model presented in Wong et al. (2006). It 
was demonstrated that time dependent variation of the SI(t) 
insulin sensitivity and the fractional nonlinear form in (2/a) 
and (2/c) can be captured in the scheduling parameters ρ(t) 
and qALPV form can be realized. Moreover, the model can 
be reduced to a second order system (Kovács et al. (2010)). 
Consequently, for the updated Canterbury-model (Suhaimi et 
al. (2010)) of (1) the scheduling parameters can be also 
defined for qALPV description: 
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Hence, in (7) the parameter matrices become: 
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The vertex defined by the scheduling parameters is presented 
in Fig. 2. It can be seen the parameters are upper and lower 
bounded (Table 2) satisfying the qALPV modeling condition. 
 
Fig. 2. Vertex defined by the scheduling parameters ( )21, ρρ . 
Table 2. Bounds of scheduling parameters. 
 By 
measurement Theoretical bound 
ρ1 
1
ρ  0.0019 0  (if I → 0) 
1ρ  0.0034 0.0146 (if I → ∞) 
ρ2 
2
ρ  0.9672 0 (if I → ∞) 
2ρ  0.9841 1 (I → 0) 
 
 
 
   
 
4.3 Question of stability 
The stability requirements are treated in the sequel. The 
insulin inlet uses a parameter dependent gain. Therefore: 
)(KB)(A)(Acl ρρρ 2+=  (12) 
22110 KKK)(K ρρρ ++=  (13) 
Acl(ρ) is the closed loop parameter varying matrix and K(ρ) is 
the state feedback term. As a result, the quadratically 
stabilizing parameter dependent Lyapunov criterion is:: 
++=+ Q))(KB)(A()(QAQ)(A Tclcl ρρρρ 2  
02 <++ ))(KB)(A(Q ρρ  (14) 
where Q is the solution matrix. 
5. RESULTS 
The robust TGC ICU controller is designed and applied 
through the model-based diabetic patient system (1). 
Regarding the choice of the weighting functions, the input 
multiplicative weight Wm, comprehends the neglected 
actuator dynamics. At low frequency, where the linear model 
is supposed to be satisfactory, the relative mismatch was 
adjusted to 10%. Moreover, above 1 rad/min it starts to grow 
up (the cross over frequency is about 30 rad/min) and at 
higher frequency shape the linear model is fully uncertain, 
the weight is over 100%. To assure the good tracking 
performance We was increased at lower frequency up to 100. 
Based on the small gain theorem (Zhou (1996)) the permitted 
tracking error in this range is over 0.01 μU/ml. More the 
weight is decreased in frequency, more the tracking slip is. 
Uncertain system can not be forced to properly follow the 
reference signal. A slightly damped dynamic input weight is 
applied to filter the disturbance input, the glucose inlet. The 
cut off frequency of the Wd is around 20 rad/min. Usually, 
measurement noise corrupts the outputs. The general 
percentage of the incorporating noise, by channel, might not 
be over 2−5%. During the design process Wn anticipates 5% 
measurement noise. The synthesis is high sensitive even for a 
moderated change in the error term of insulin noise. The 
control input, i.e. the insulin inlet was maximized, because 
one can not use as many control energy as desired. The input 
inverse scale Wu permits to use a maximal, normalized and 
constant control input 38.525 μU/min (Parker et al. (2000)). 
Fig.3 plots the weighting functions used in Fig.1. 
One can easily understand, by adopting the H∞ synthesis 
method (e.g. γ-iteration), that the robust performance 
prescription can not be achieved (Table 3). By µ-synthesis a 
less conservative solution can be given. The final D scale 
assures the robust stability (the value of µ is under 1). 
Consequently, robust performance is met. However, the 
controller degree increased significantly. 
In case of qALPV method by the bounded scheduling 
parameters the nonlinear control input can be calculated, 
obtaining: 
720480 212 .xxx.uqALPV −+−=  (15) 
 
Fig. 3. The frequency response of some weighting functions 
in case of the model of Suhaimi et al. (2010). 
Table 3. D-K iteration summary. 
Iteration 1 2 3 
Controller order 6 12 12 
D-scale order 0 6 6 
Gamma 1.563 1.115 1.018 
Peak value of µ 1.099 1.006 0.997 
 
For a theoretical food intake scenario (Kovács et al (2005)): 
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glucose output concentration can be seen Fig. 4. 
Here one can see a comparison of linear and nonlinear 
model-based control strategies too. In the mixed µ case the 
tracking error is lower than in the qALPV control system, but 
one needs to emphasize that the linear control is working 
properly around the operating point with the uncertainty and 
other weights previewed. However, the LPV system is valid 
for the whole working domain being equal with the original 
nonlinear system. 
 
Fig. 4. Variation of glucose concentration in case of LPV and 
µ-synthesis methods. 
 
 
   
 
6. CONCLUSIONS 
Linear robust µ-synthesis design (assuring RP with structure-
ing the uncertainty description) and nonlinear qALPV 
method were applied on a frequently used ICU metabolic 
model validated in clinical trials. The µ-synthesis (D−K 
iteration) method proved to guarantee robust performance if 
one remains in the given interval of the planned uncertainty. 
However, if one steps out from these bounds LPV control 
could be more efficient. The paper presents also the closed, 
glucose-insulin loop qALPV problem. The nonlinear problem 
was transformed into linear, but parameter dependent form. 
Further research will be done on simulating the designed 
controllers on real ICU data of different patients. Other 
clinically validated ICU models will be also investigated. 
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